The drug development and approval process can be difficult to understand. Below is a video developed by Policy Matters Canada which explains the drug approval process in Canada. CAPA works hard to inform policy-makers why access to approved drugs in important for all arthritis patients. We do this in part by participating in the CADTH drug review process. More information is included below the video.

 

To learn more about the process of the CADTH and to view our patient input submissions, click here.